X-chromosomale Dystrophinopathien und Duchenne-Muskeldystrophie von Roy Strowd, MD

video locked

Über den Vortrag

Der Vortrag „X-chromosomale Dystrophinopathien und Duchenne-Muskeldystrophie“ von Roy Strowd, MD ist Bestandteil des Kurses „Erbliche neuromuskuläre Erkrankungen“.


Quiz zum Vortrag

  1. Young boy
  2. Middle-aged woman
  3. Distal muscle involvement
  4. Low CK levels
  1. Difficulty getting up from a seated position
  2. Average jumping and running capability for age
  3. Normal CK levels
  4. Calf muscle wasting
  5. Weakness developing in early adulthood
  1. Respiratory muscle involvement results in pneumonia and ultimately death.
  2. Patients with this disease will live largely normal lives until late adulthood.
  3. Gender does not impact life expectancy from this disease
  4. There are therapeutic options at this time.
  5. Once diagnosed, the patient’s symptoms are likely to improve with time.
  1. It acts as a bridging oligonucleotide, allowing some dystrophin to be synthesized by the patient.
  2. The treatment has equal efficacy for all patients with Duchenne’s MD.
  3. The drug is a synthetic version of physiologic dystrophin.
  4. The mechanism is considered intron-skipping therapy.
  5. This treatment is curative for most patients.

Dozent des Vortrages X-chromosomale Dystrophinopathien und Duchenne-Muskeldystrophie

 Roy Strowd, MD

Roy Strowd, MD

Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.


Kundenrezensionen

(1)
5,0 von 5 Sternen
5 Sterne
5
4 Sterne
0
3 Sterne
0
2 Sterne
0
1  Stern
0